Balloon- Versus Self-Expanding Intraannular TAVI in Small Aortic Annuli
NCT: NCT07794306 · NOT_YET_RECRUITING
Brief Summary
In Europe TAVI is now recommended for treatment of aortic valve stenosis from the age of 70 years. When performing TAVI in young patients, lifetime management becomes important in terms of anticipated TAVI-in-TAVI procedures when valve deterioration occures. Especially small aortic annuli represent a special challenge in terms of postprocedural hemodynamics, however intra-annular transcatheter heart valve designs should be the devices of choice to facilitate future TAVI-in-TAVI procedures. Which intra-annular valve design offers ideal clinical and hemodynamic efficacy is unclear. Therefore, an investigator-initiated, randomized controlled trial (BALANCE trial: Balloon- vs. Self-expanding intraannular TAVI in small aortic annuli) was created to elucidate this topic.
Frequently Asked Questions
What is Balloon- Versus Self-Expanding Intraannular TAVI in Small Aortic Annuli?
Balloon- Versus Self-Expanding Intraannular TAVI in Small Aortic Annuli is a clinical trial registered under NCT07794306. Current status: NOT_YET_RECRUITING.
What is the status of NCT07794306?
The current status of NCT07794306 (Balloon- Versus Self-Expanding Intraannular TAVI in Small Aortic Annuli) is: NOT_YET_RECRUITING.
When did Balloon- Versus Self-Expanding Intraannular TAVI in Small Aortic Annuli start?
Balloon- Versus Self-Expanding Intraannular TAVI in Small Aortic Annuli started on 2026-10-26.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.